InvestorsHub Logo
Replies to #846 on SCYNEXIS (SCYX)

BooDog

05/12/23 8:58 AM

#847 RE: subslover #846

SCYNEXIS Reports Closing of Exclusive License Agreement with GSK for BREXAFEMME® (Ibrexafungerp Tablets)

Thinking the gap continues to go unfilled. :-)


https://finance.yahoo.com/news/scynexis-reports-closing-exclusive-license-120000142.html
Bullish
Bullish